Physician profile
Morris M Silver
NPI 1285636779
$2,816.72
in general payments reported to CMS, 2019-2025
13 companies · $219 in 2025
The $219 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $173 · 2021: $232 · 2022: $69.45 · 2023: $1,582 · 2024: $131 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,124 · Travel and Lodging: $785 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,124.00 |
| Travel and Lodging | $784.90 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,508.37 | 2023-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $405.80 | 2021-2025 | Interstim |
| Medtronic USA, INC. | $247.31 | 2019-2020 | |
| Ethicon US, LLC | $184.20 | 2020-2023 | Vistaseal |
| Boston Scientific Corporation | $135.00 | 2019-2024 | Solyx Sis System |
| Aspira Women'S Health INC | $117.20 | 2021 | |
| Medical Device Business Services, INC. | $86.05 | 2019 | |
| Pfizer INC. | $55.33 | 2022-2024 | |
| Axonics, INC. | $19.30 | 2021 | |
| Amag Pharmaceuticals, INC. | $16.96 | 2019 | |
| Abbvie INC. | $13.97 | 2020 | |
| Astellas Pharma US INC | $13.70 | 2025 | Veozah |
| Allergan, INC. | $13.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morris Silver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.